• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Insights into structural and binding studies of pollen allergen Bet v 1 using computational approaches.利用计算方法对花粉过敏原Bet v 1进行结构和结合研究的见解。
In Silico Pharmacol. 2025 Jan 11;13(1):14. doi: 10.1007/s40203-024-00303-3. eCollection 2025.
2
ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis.ImmunoCAP® ISAC和微量试验用于难治性过敏性疾病患者的多重过敏原检测:系统评价与成本分析
Health Technol Assess. 2016 Sep;20(67):1-178. doi: 10.3310/hta20670.
3
Specific allergen immunotherapy for the treatment of atopic eczema.特异性变应原免疫疗法治疗特应性皮炎
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008774. doi: 10.1002/14651858.CD008774.pub2.
4
Sublingual immunotherapy for allergic rhinitis.过敏性鼻炎的舌下免疫疗法。
Cochrane Database Syst Rev. 2003(2):CD002893. doi: 10.1002/14651858.CD002893.
5
Characterization of the clinical relevance and hypoallergenic peptides of the newly evidenced major allergen Hum j 1.新证实的主要过敏原Hum j 1的临床相关性及低致敏性肽的特性分析
Front Immunol. 2025 Jun 23;16:1588870. doi: 10.3389/fimmu.2025.1588870. eCollection 2025.
6
Probiotics in infants for prevention of allergic disease.婴儿使用益生菌预防过敏性疾病。
Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3.
7
Skin care interventions in infants for preventing eczema and food allergy.婴幼儿皮肤护理干预措施预防特应性皮炎和食物过敏。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013534. doi: 10.1002/14651858.CD013534.pub3.
8
Allergen-specific oral immunotherapy for peanut allergy.针对花生过敏的过敏原特异性口服免疫疗法。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009014. doi: 10.1002/14651858.CD009014.pub2.
9
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.舌下免疫疗法治疗变应性鼻炎:系统评价与Meta分析
Allergy. 2005 Jan;60(1):4-12. doi: 10.1111/j.1398-9995.2005.00699.x.
10
Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.低剂量白细胞介素-2治疗桦树花粉过敏:一项2期随机双盲安慰剂对照试验。
J Allergy Clin Immunol. 2025 Feb;155(2):650-655. doi: 10.1016/j.jaci.2024.10.033. Epub 2024 Nov 10.

本文引用的文献

1
Profiles of Birch Allergen Component Sensitization and Its Association with Pollen Food Allergy Syndrome in Northern China.中国北方桦树过敏原成分致敏情况及其与花粉食物过敏综合征的关联
J Asthma Allergy. 2023 Nov 14;16:1241-1250. doi: 10.2147/JAA.S427764. eCollection 2023.
2
Birch pollen-The unpleasant herald of spring.桦树花粉——春天令人不悦的先兆。
Front Allergy. 2023 May 15;4:1181675. doi: 10.3389/falgy.2023.1181675. eCollection 2023.
3
Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.用于定量测定桦树花粉过敏原 Bet v 1 的参考抗体的表位特异性特征描述。
Allergy. 2018 May;73(5):1032-1040. doi: 10.1111/all.13364. Epub 2017 Dec 12.
4
EAACI Molecular Allergology User's Guide.欧洲变态反应和临床免疫学会分子变态反应学用户指南
Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250. doi: 10.1111/pai.12563.
5
mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.mCSM-AB:一个用于通过基于图形的特征预测突变后抗体-抗原亲和力变化的网络服务器。
Nucleic Acids Res. 2016 Jul 8;44(W1):W469-73. doi: 10.1093/nar/gkw458. Epub 2016 May 23.
6
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.SWISS-MODEL:利用进化信息进行蛋白质三级和四级结构建模。
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8. doi: 10.1093/nar/gku340. Epub 2014 Apr 29.
7
Current overview of allergens of plant pathogenesis related protein families.植物病程相关蛋白家族过敏原的当前概述。
ScientificWorldJournal. 2014 Feb 16;2014:543195. doi: 10.1155/2014/543195. eCollection 2014.
8
Human IgE against the major allergen Bet v 1--defining an epitope with limited cross-reactivity between different PR-10 family proteins.人 IgE 针对主要过敏原 Bet v 1——定义不同 PR-10 家族蛋白之间具有有限交叉反应性的表位。
Clin Exp Allergy. 2014 Feb;44(2):288-99. doi: 10.1111/cea.12230.
9
Aerial pollen diversity in India and their clinical significance in allergic diseases.印度的气传花粉多样性及其在过敏性疾病中的临床意义。
Indian J Clin Biochem. 2004 Jul;19(2):190-201. doi: 10.1007/BF02894284.
10
An IgE epitope of Bet v 1 and fagales PR10 proteins as defined by a human monoclonal IgE.一种由人源单克隆 IgE 定义的 Bet v 1 和杨柳科 PR10 蛋白的 IgE 表位。
Allergy. 2012 Dec;67(12):1530-7. doi: 10.1111/all.12045. Epub 2012 Oct 16.

利用计算方法对花粉过敏原Bet v 1进行结构和结合研究的见解。

Insights into structural and binding studies of pollen allergen Bet v 1 using computational approaches.

作者信息

Pandit Mansi, Narayanasamy Nandita, Latha N

机构信息

Bioinformatics Infrastructure Facility, Sri Venkateswara College (University of Delhi), Benito Juarez Road, Dhaula Kuan, New Delhi, 110021 India.

Department of Biochemistry, Sri Venkateswara College (University of Delhi), Benito Juarez Road, Dhaula Kuan, New Delhi, 110021 India.

出版信息

In Silico Pharmacol. 2025 Jan 11;13(1):14. doi: 10.1007/s40203-024-00303-3. eCollection 2025.

DOI:10.1007/s40203-024-00303-3
PMID:39807173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724816/
Abstract

UNLABELLED

Bet v 1, the European White Birch tree pollen allergen is responsible for a number of allergic responses in humans such as rhinitis, asthma and oral allergy syndrome. The allergen belongs to pathogenesis-related (PR) class 10 protein superfamily and exists in several naturally occurring isoforms. Limited structural information on Bet v 1 isoallergens and variants prompted us to carry out their in silico structural characterization. In this study, three-dimensional structures of Bet v 1 isoallergens were predicted followed by allergen-antibody docking with Bet v 1- specific human IgE. Further, molecular dynamics simulations were performed for the allergen-antibody complexes. In addition, in silico mutagenesis was carried out for the design of a hypoallergenic variant of Bet v 1. Our study aimed to elucidate the differential ability of Bet v 1 isoallergens in eliciting allergic responses based on structural features and also identified a potential hypoallergen allowing us to propose it as a promising candidate for treating birch pollen-induced allergy.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s40203-024-00303-3.

摘要

未标注

欧洲白桦树花粉过敏原Bet v 1会引发人类的多种过敏反应,如鼻炎、哮喘和口腔过敏综合征。该过敏原属于病程相关(PR)10类蛋白超家族,存在多种天然存在的异构体。关于Bet v 1同种过敏原和变体的结构信息有限,促使我们对其进行计算机结构表征。在本研究中,预测了Bet v 1同种过敏原的三维结构,随后将过敏原与Bet v 1特异性人IgE进行抗体对接。此外,对过敏原-抗体复合物进行了分子动力学模拟。此外,还进行了计算机诱变,以设计一种低过敏原性的Bet v 1变体。我们的研究旨在根据结构特征阐明Bet v 1同种过敏原引发过敏反应的差异能力,并确定一种潜在的低过敏原,使我们能够将其作为治疗桦树花粉诱导过敏的有前景的候选物提出。

补充信息

在线版本包含可在10.1007/s40203-024-00303-3获取的补充材料。